Gene mutations in myeloproliferative neoplasms

Marito Araki1, Soji Morishita, Norio Komatsu

  • 1Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine.

Insights

Recent advances in myeloproliferative neoplasms (MPNs) reveal key gene mutations like JAK2, CALR, and MPL. Understanding these genetic factors is crucial for MPN development, though some mutations in healthy individuals complicate the full picture.

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • Myeloproliferative neoplasms (MPNs) are a group of clonal hematopoietic stem cell disorders.
  • The genetic landscape of MPNs is complex, involving both disease-specific and common mutations.

Purpose of the Study:

  • To review recent advances in understanding gene alterations in MPNs.
  • To describe the roles of genetic factors in MPN development and pathogenesis.

Main Methods:

  • Review of current literature on genetic mutations in MPNs.
  • Analysis of the functional impact of specific mutations (JAK2, CALR, MPL) on cytokine receptor signaling.
  • Examination of synergistic effects of common and disease-specific mutations.

Main Results:

  • Specific mutations (JAK2, CALR, MPL) constitutively activate cytokine receptors in MPN patients.
  • Common mutations in hematopoietic malignancies can accelerate MPN development or define subtypes when combined with specific mutations.
  • Some identified mutations are present in healthy elderly individuals, indicating incomplete understanding of MPN etiology.

Conclusions:

  • Genetic factors play a significant role in MPN development.
  • Further research into genetic factors is essential for a comprehensive understanding of MPN pathogenesis.
  • Elucidating the role of mutations found in healthy individuals may reveal critical insights into MPN initiation.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.0K
Mutations01:39

Mutations

Overview
95.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.7K